查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092039

乳房切片設備市場－2026-2032年全球市場預測

Breast Biopsy Device Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，乳房切片設備市場規模將達到 38.1 億美元，複合年成長率為 6.70%。

主要市場統計數據
基準年 2025 24.2億美元
預計年份：2026年 25.7億美元
預測年份 2032 38.1億美元
複合年成長率 (%) 6.70%

關於乳房切片設備的執行摘要

隨著醫學界將乳癌的早期診斷、影像引導組織取樣、微創手術以及支持快速臨床決策的病理工作流程列為優先事項，乳房切片設備的市場持續成長。乳房切片設備用於採集透過乳房X光攝影、超音波、磁振造影（MRI）、斷層合成或臨床檢查發現的乳房可疑病變組織。空芯針穿刺活體組織切片、真空輔助乳房切片、細針穿刺切片檢查、定位系統、切片檢查引導附件、標記物和自動化切片檢查設備在確診惡性腫瘤、闡明腫瘤生物學特徵以及製定治療方案方面發揮核心作用。

乳房切片技術的革命性變革

隨著手術切除向影像引導下微創乳房組織採集的轉變，乳房切片器械的格局正在改變。超音波導引、立體定位引導、磁振造影引導和斷層合成引導的切片檢查方法正在擴展臨床工具箱，使醫生能夠根據病灶的可見性、乳房密度、位置、患者的解剖特徵以及手術環境來選擇合適的器械。真空輔助切片檢查在採集小型或難以觸及的病灶方面仍然發揮著越來越重要的作用，因為它允許在一次穿刺中採集更大、更連續的組織標本，從而提高診斷的準確性並降低採集不足的可能性。

人工智慧（AI）的累積影響

人工智慧正透過提高檢測準確率、病灶特徵分析、最佳化工作流程優先順序和改善手術方案規劃，對乳房切片設備生態系統產生影響。人工智慧驅動的乳房攝影影像工具正被用於輔助放射科醫生識別乳房X光攝影光攝影、超音波、磁振造影和斷層合成影像中的可疑觀察，從而影響切片檢查的預約模式，並有助於規範需要組織學確診的病灶的評估。雖然人工智慧不會取代組織病理學，但它正透過改善分診、減少解讀差異以及識別需要更詳細評估的病例，日益為切片檢查流程提供支援。

關於乳房切片設備的關鍵區域性見解

在亞太地區，由於乳癌篩檢意識的提高、影像基礎設施投資的增加以及獲得腫瘤專科和乳癌診療服務的便利性改善，乳房切片設備的應用正在不斷推進。在醫療體系完善的國家，影像導引切片檢查技術已在醫院和門診中得到應用；而在新興經濟體，重點則在於提高超音波導引切片檢查和粗針穿刺切片技術的普及率。加之該地區女性人口眾多且老化嚴重，以及系統化和自動化篩檢帶來的檢測率提升，對精準乳房組織診斷的臨床需求持續成長。

策略市場關鍵群分析

在東南亞國協，隨著區域醫療體系內癌症篩檢、影像檢查和轉診途徑不斷擴展，乳房切片基礎設施正在不斷改進。各成員國的具體實施情況有所不同；先進的都市區醫院採用影像引導和真空輔助切片檢查技術，而資源匱乏的地區則優先考慮實用且經濟的中空針切片檢查方案，並可與超音波診斷設備聯合使用。人們對乳癌的認知不斷提高，以及公共和私人醫療投資的增加，正在改善東南亞國協的診斷服務。

主要國家引入乳房切片方法的分析

美國擁有世界上最先進的乳房切片設備體系之一，這得益於其廣泛的篩檢覆蓋、先進的乳房攝影影像技術、門診切片檢查能力以及影像引導下經皮的積極應用。加拿大透過省級篩檢計畫和醫院影像網路，採用實證乳癌診斷路徑，並專注於品質保證和公平獲取醫療服務。墨西哥正透過公共和私人醫療保健投資擴大其診斷能力，但先進的切片檢查系統仍集中在主要都市區。

為行業領導者提供的實用建議

產業領導者應優先切片檢查能夠提高超音波引導、立體定向引導、磁振造影引導和斷層合成引導活體組織切片流程中靶點定位精度、檢體品質、手術效率和病患舒適度的醫療器材。研發策略應著重於與最新乳房攝影成像醫療設備的兼容性、直覺的人體工學設計、可靠的標記定位、縮短設定時間以及簡化放射科醫生、外科醫生和技術人員的培訓。

調查方法

評估乳房切片設備現況的調查方法結合了二手資料研究、一手檢驗和結構化分析綜述。二手資料研究包括查閱臨床指南、監管文件、公共衛生資料、同行評審的醫學文獻、設備安全資訊、癌症篩檢建議以及醫療基礎設施指標。資訊來源的可靠性、及時性、相關性和方法透明度均經過評估。

結論

乳房切片設備是現代乳癌診斷的關鍵，它能夠以微創方式取得組織樣本，從而確認影像學觀察的可疑病灶，並支持及時制定治療方案。該領域正透過影像引導的精準性、真空輔助取樣、工作流程整合以及與以患者為中心的醫療模式的日益整合而不斷進步。人工智慧 (AI) 透過改善病灶檢測、分診、治療計畫和品質保證，提升了整個診斷流程。同時，區域部署也受到篩檢率、影像基礎設施、專家資源、保險報銷和監管標準的影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章乳房切片設備市場：依產品分類

  • 檢測試劑盒
  • 切片穿刺針
  • 切片檢查台
  • 導航系統
  • 定位線

第8章：乳房切片設備市場：依手術類型分類

  • 粗針穿刺切片
  • 細針穿刺法
  • 真空輔助切片檢查

第9章：乳房切片設備市場：依方法分類

  • 磁共振引導
  • 立體定位
  • 斷層合成引導型
  • 超音波引導

第10章：乳房切片設備市場：依類別分類

  • 自動切片檢查裝置
  • 手動切片檢查裝置

第11章乳房切片設備市場：依應用領域分類

  • 良性病變的診斷
  • 惡性病變的診斷

第12章乳房切片設備市場：依最終用戶分類

  • 門診手術中心
  • 診斷影像中心
  • 醫院

第13章：乳房切片設備市場：依分銷管道分類

  • 線下銷售
  • 線上銷售

第14章乳房切片設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章乳房切片設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章乳房切片設備市場：按國家/地區分類

  • 美國
  • 德國
  • 中國
  • 英國
  • 印度
  • 日本
  • 俄羅斯
  • 巴西
  • 加拿大
  • 義大利
  • 墨西哥
  • 法國
  • 西班牙
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Advin Health Care
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Danaher Corporation
  • FUJIFILM Corporation
  • General Electric Company
  • Halma plc
  • Hologic, Inc
  • INRAD Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Ningbo Xinwell Medical Technology Co., LTD.
  • PAJUNK GmbH
  • Planmeca Oy
  • Point Blank Medical
  • Siemens AG
  • SNVL Varay Laborix
  • STERYLAB Srl
  • Suretech Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vector Medical, Inc.
  • Zamar Care
Product Code: MRR-807A20B5CD96

The Breast Biopsy Device Market is projected to grow by USD 3.81 billion at a CAGR of 6.70% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.57 billion
Forecast Year [2032] USD 3.81 billion
CAGR (%) 6.70%

Breast Biopsy Device Executive Summary

The breast biopsy device landscape is advancing as healthcare systems prioritize earlier breast cancer diagnosis, image-guided tissue sampling, minimally invasive procedures, and pathology workflows that support faster clinical decision-making. Breast biopsy devices are used to obtain tissue from suspicious breast lesions identified through mammography, ultrasound, magnetic resonance imaging, tomosynthesis, or clinical examination. Core needle biopsy, vacuum-assisted breast biopsy, fine needle aspiration, localization systems, biopsy guidance accessories, markers, and automated biopsy guns are central to confirming malignancy, characterizing tumor biology, and guiding treatment planning.

Demand is supported by well-established clinical evidence showing that image-guided percutaneous biopsy has largely replaced open surgical biopsy for many suspicious breast findings because it can reduce patient trauma, shorten recovery time, and support outpatient care. Screening programs, greater breast cancer awareness, expanded access to diagnostic imaging, and the increasing use of digital breast tomosynthesis are strengthening the role of biopsy devices in the diagnostic pathway. At the same time, providers are seeking devices that improve sample adequacy, minimize repeat procedures, enable accurate lesion targeting, and integrate smoothly with radiology, surgery, and pathology teams.

The industry is shaped by regulatory emphasis on device safety, sterility, traceability, and clinical performance, along with purchasing decisions that increasingly consider total procedural efficiency rather than device price alone. Hospitals, breast imaging centers, ambulatory surgical centers, and diagnostic clinics are evaluating breast biopsy technology through the lens of patient experience, radiologist confidence, workflow compatibility, and compatibility with evolving imaging platforms.

Transformative Shifts in Breast Biopsy Technology

The breast biopsy device landscape is being transformed by the shift from surgical excision toward image-guided, minimally invasive breast tissue sampling. Ultrasound-guided, stereotactic-guided, MRI-guided, and tomosynthesis-guided biopsy approaches are expanding the clinical toolkit, allowing physicians to select devices based on lesion visibility, breast density, location, patient anatomy, and procedural setting. Vacuum-assisted biopsy continues to gain relevance for sampling small or difficult-to-access lesions because it can collect larger contiguous tissue specimens through a single insertion, supporting diagnostic confidence and reducing the likelihood of inadequate sampling.

Another major shift is the integration of biopsy workflows with advanced breast imaging. Digital breast tomosynthesis has improved lesion detection, especially in dense breast tissue, and has increased the importance of precise localization and compatible biopsy systems. Marker deployment, specimen radiography, navigation aids, and imaging-compatible needles are becoming critical elements of a complete breast biopsy workflow. Healthcare providers are also emphasizing shorter procedure times, reduced patient discomfort, lower complication risk, and fewer repeat visits.

Procedure decentralization is also changing adoption patterns. Specialized breast centers and outpatient diagnostic facilities are increasingly equipped to perform percutaneous breast biopsy, which supports faster diagnosis and reduces pressure on hospital operating rooms. This shift favors ergonomic, reliable, easy-to-train devices that can be used consistently across high-throughput imaging environments. In parallel, reimbursement scrutiny and value-based care models are pushing procurement teams to assess clinical outcomes, sample quality, workflow efficiency, and lifecycle costs together.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is influencing the breast biopsy device ecosystem by improving detection, lesion characterization, workflow prioritization, and procedural planning. AI-enabled breast imaging tools are being used to assist radiologists in identifying suspicious findings on mammography, ultrasound, MRI, and tomosynthesis, which can affect biopsy referral patterns and help standardize assessment of lesions requiring tissue confirmation. While AI does not replace histopathology, it increasingly supports the pathway leading to biopsy by improving triage, reducing reading variability, and flagging cases that may require closer evaluation.

In procedural settings, AI-driven image analysis and computer-assisted guidance have the potential to improve targeting precision, particularly for small lesions, architectural distortions, calcifications, and abnormalities visible only on specific imaging modalities. AI can also support quality assurance by helping evaluate biopsy adequacy, correlate imaging findings with pathology results, and detect discordance between radiologic suspicion and histologic outcomes. These applications are especially important in breast centers managing high procedure volumes.

The cumulative impact of AI is also visible in operational efficiency. Automated scheduling support, image prioritization, structured reporting, and decision-support tools can help reduce delays between suspicious imaging findings and biopsy completion. However, implementation depends on validated algorithms, transparent clinical performance, regulatory clearance, interoperability with imaging and reporting systems, and clinician trust. For breast biopsy device stakeholders, AI is becoming less of a standalone feature and more of an enabling layer that strengthens the diagnostic continuum from screening to tissue diagnosis.

Key Regional Insights for Breast Biopsy Devices

In Asia-Pacific, breast biopsy device adoption is influenced by expanding breast cancer screening awareness, rising investment in diagnostic imaging infrastructure, and growing availability of specialized oncology and breast care services. Countries with advanced healthcare systems are adopting image-guided biopsy technologies across hospital and outpatient settings, while emerging economies are focused on improving access to ultrasound-guided and core needle biopsy procedures. The region's large and aging female population, combined with increasing detection through organized and opportunistic screening, supports sustained clinical need for accurate breast tissue diagnosis.

North America remains highly advanced in breast biopsy practice due to widespread access to mammography, ultrasound, MRI, digital breast tomosynthesis, accredited breast imaging centers, and established clinical guidelines that support percutaneous image-guided biopsy. The region emphasizes patient-centered diagnostics, radiology-pathology concordance, quality metrics, and rapid transition from abnormal screening findings to tissue confirmation. Adoption is also supported by mature reimbursement structures and strong utilization of minimally invasive breast biopsy techniques.

Latin America is progressing through wider access to diagnostic imaging, public health initiatives focused on breast cancer awareness, and investments in oncology services across urban centers. Adoption varies significantly by country and healthcare setting, with private networks generally having greater access to stereotactic, ultrasound-guided, and vacuum-assisted biopsy systems. Efforts to improve early diagnosis are increasing the importance of cost-effective and durable breast biopsy devices suitable for diverse clinical environments.

Europe benefits from structured breast cancer screening programs, strong radiology standards, and broad use of image-guided percutaneous biopsy as part of multidisciplinary breast cancer care. Western European countries typically show high adoption of advanced biopsy guidance and marker technologies, while Central and Eastern European systems continue strengthening access to modern breast diagnostics. Regulatory alignment, clinical evidence requirements, and emphasis on patient safety shape device selection across the region.

The Middle East is seeing growing demand for breast biopsy devices as governments invest in cancer care infrastructure, women's health services, and diagnostic imaging capacity. Gulf countries are increasingly adopting advanced breast imaging and biopsy platforms in tertiary hospitals and private medical centers, while broader regional access depends on healthcare investment, specialist availability, and screening participation. Rising awareness campaigns are contributing to earlier evaluation of suspicious breast findings.

Africa presents a heterogeneous landscape in which breast biopsy device access is closely tied to diagnostic infrastructure, trained radiology and pathology workforce availability, and oncology referral networks. Urban tertiary hospitals and private centers are more likely to offer image-guided biopsy, while many areas continue to face barriers related to screening coverage, imaging availability, and pathology turnaround. Improving access to reliable core needle biopsy and ultrasound-guided procedures is essential for earlier breast cancer diagnosis across the continent.

Key Group Insights Across Strategic Markets

ASEAN countries are strengthening breast biopsy capabilities as regional health systems expand cancer screening, diagnostic imaging, and specialist referral pathways. Adoption is uneven across member states, with advanced urban hospitals using image-guided and vacuum-assisted biopsy technologies, while resource-constrained settings prioritize practical, affordable core needle biopsy solutions that can be deployed alongside ultrasound systems. Rising breast cancer awareness and public-private healthcare investment are improving diagnostic access across the group.

The GCC shows strong momentum in advanced breast biopsy adoption, supported by investments in tertiary care, women's health programs, oncology centers, and imaging technology. Hospitals in the group increasingly emphasize minimally invasive breast biopsy, multidisciplinary cancer pathways, and rapid diagnosis. Higher availability of digital breast imaging and specialist radiology services supports uptake of stereotactic, MRI-guided, and vacuum-assisted biopsy systems in leading facilities.

The European Union is characterized by structured breast screening programs, harmonized emphasis on medical device regulation, and strong clinical standards for breast cancer diagnosis. EU healthcare systems generally support image-guided percutaneous biopsy as a preferred diagnostic approach for suspicious breast lesions, with procurement shaped by safety, clinical evidence, usability, interoperability, and compliance requirements. Cross-border regulatory consistency supports quality expectations, though adoption levels differ by national healthcare funding and regional service capacity.

BRICS countries represent a diverse set of opportunities and challenges. China and India are expanding breast imaging and biopsy access through hospital modernization and cancer care investment, while Brazil, Russia, and South Africa show varying levels of infrastructure development and regional disparity. Across the group, improving early breast cancer diagnosis, scaling pathology capacity, and broadening access beyond major cities are central to device adoption.

The G7 countries generally have mature diagnostic ecosystems, established cancer screening practices, advanced imaging infrastructure, and clinical pathways that favor minimally invasive biopsy before surgical intervention. Procurement in these countries is closely linked to performance evidence, workflow efficiency, patient comfort, sterility assurance, and compatibility with advanced breast imaging. High procedural standards support continued adoption of precision biopsy systems and related accessories.

NATO member countries include a mix of highly mature healthcare systems and developing diagnostic networks, creating varied breast biopsy device adoption patterns. Members with strong public screening systems and advanced radiology capacity tend to use a broad range of image-guided biopsy platforms, while others focus on improving access to core biopsy, ultrasound guidance, and pathology linkage. Across the group, healthcare resilience, supply security, and standardization of medical technology procurement are increasingly relevant considerations.

Key Country Insights for Breast Biopsy Adoption

The United States has one of the most developed breast biopsy device environments, supported by broad screening access, advanced breast imaging, outpatient biopsy capacity, and strong use of image-guided percutaneous procedures. Canada follows evidence-based breast cancer diagnostic pathways through provincial screening programs and hospital-based imaging networks, with emphasis on quality assurance and equitable access. Mexico is expanding diagnostic capacity through public and private healthcare investments, though access to advanced biopsy systems remains more concentrated in major urban centers.

Brazil is the largest healthcare market in Latin America and has growing demand for breast biopsy devices as screening awareness, oncology services, and diagnostic imaging capacity improve, although regional access disparities remain significant. The United Kingdom relies on structured breast screening and multidisciplinary cancer pathways, supporting consistent use of core needle and vacuum-assisted biopsy in specialist breast units. Germany has a highly developed diagnostic infrastructure with strong adoption of advanced imaging-guided biopsy, while France emphasizes organized screening, radiology standards, and integrated breast cancer care. Russia's adoption is shaped by modernization of oncology services and regional differences in imaging and pathology capacity. Italy and Spain maintain established breast screening and diagnostic programs, supporting ongoing use of minimally invasive biopsy devices across public and private settings.

China is expanding breast biopsy device utilization through rapid growth in hospital infrastructure, advanced imaging adoption, and increasing cancer awareness, with major cities leading uptake of sophisticated biopsy guidance systems. India presents substantial clinical need as breast cancer detection increases and private diagnostic networks expand, but access remains uneven across urban and rural settings, making cost-effective ultrasound-guided and core needle biopsy solutions especially important. Japan has advanced imaging infrastructure, a strong clinical focus on early diagnosis, and adoption of precise, minimally invasive biopsy workflows. Australia benefits from organized screening, established breast care pathways, and access to advanced diagnostic technologies, while South Korea combines high technology adoption, strong imaging capacity, and growing emphasis on early cancer detection to support sophisticated breast biopsy practices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize device designs that improve targeting accuracy, specimen quality, procedural efficiency, and patient comfort across ultrasound-guided, stereotactic-guided, MRI-guided, and tomosynthesis-guided biopsy workflows. Development strategies should focus on compatibility with modern breast imaging systems, intuitive ergonomics, reliable marker deployment, reduced setup time, and simplified training for radiologists, surgeons, and technologists.

Manufacturers and channel partners should align product portfolios with varied healthcare settings. Mature markets require advanced workflow integration, quality assurance features, and evidence demonstrating clinical performance, while emerging markets often need durable, cost-effective devices that support core biopsy and ultrasound-guided procedures in expanding diagnostic networks. Building education programs around radiology-pathology concordance, sample adequacy, infection control, and complication reduction can strengthen adoption.

Commercial strategies should address the full diagnostic pathway rather than positioning breast biopsy devices as standalone products. Partnerships with imaging centers, pathology providers, breast care clinics, and hospital procurement teams can improve value demonstration. Leaders should also prepare for AI-enabled workflow integration by ensuring device data, imaging outputs, and procedural documentation can support interoperable, quality-focused breast diagnostics.

Research Methodology

The research methodology for evaluating the breast biopsy device landscape combines secondary research, primary validation, and structured analytical review. Secondary research includes examination of clinical guidelines, regulatory documents, public health resources, peer-reviewed medical literature, device safety communications, cancer screening recommendations, and healthcare infrastructure indicators. Sources are assessed for credibility, recency, relevance, and methodological transparency.

Primary research involves engagement with stakeholders across the breast diagnostics ecosystem, including radiologists, breast surgeons, interventional specialists, pathologists, procurement professionals, healthcare administrators, distributors, and regulatory experts. These inputs help validate device adoption patterns, procedural preferences, workflow challenges, purchasing criteria, and unmet clinical needs.

Analytical synthesis is conducted by triangulating clinical evidence, technology adoption indicators, regional healthcare capacity, regulatory requirements, and expert perspectives. The approach avoids unsupported assumptions and focuses on verified, data-backed insights related to device utilization, diagnostic pathways, procedural trends, and competitive technology dynamics without relying on market sizing or forecasting.

Conclusion

Breast biopsy devices are essential to modern breast cancer diagnosis, enabling minimally invasive tissue confirmation for suspicious imaging findings and supporting timely treatment planning. The landscape is advancing through image-guided precision, vacuum-assisted sampling, workflow integration, and greater alignment with patient-centered care. Artificial intelligence is strengthening the broader diagnostic pathway by improving lesion detection, triage, planning, and quality assurance, while regional adoption is shaped by screening coverage, imaging infrastructure, specialist availability, reimbursement, and regulatory standards.

Success in this field depends on delivering clinically reliable, easy-to-use, imaging-compatible biopsy solutions that improve sample adequacy and reduce procedural burden. Industry leaders that align technology innovation with real-world diagnostic workflows, regional access needs, and evidence-based care standards will be best positioned to support earlier breast cancer diagnosis and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Breast Biopsy Device Market, by Product

  • 7.1. Introduction
  • 7.2. Assay Kits
  • 7.3. Biopsy Needles
  • 7.4. Biopsy Tables
  • 7.5. Guidance Systems
  • 7.6. Localization Wires

8. Breast Biopsy Device Market, by Procedure Type

  • 8.1. Introduction
  • 8.2. Core Needle Biopsy
  • 8.3. Fine Needle Aspiration
  • 8.4. Vacuum Assisted Biopsy

9. Breast Biopsy Device Market, by Technique

  • 9.1. Introduction
  • 9.2. MRI Guided
  • 9.3. Stereotactic
  • 9.4. Tomosynthesis Guided
  • 9.5. Ultrasound Guided

10. Breast Biopsy Device Market, by Category

  • 10.1. Introduction
  • 10.2. Automated Biopsy Devices
  • 10.3. Manual Biopsy Devices

11. Breast Biopsy Device Market, by Application

  • 11.1. Introduction
  • 11.2. Benign Lesion Diagnosis
  • 11.3. Malignant Lesion Diagnosis

12. Breast Biopsy Device Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgery Centers
  • 12.3. Diagnostic Imaging Centers
  • 12.4. Hospitals

13. Breast Biopsy Device Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline Sales
  • 13.3. Online Sales

14. Breast Biopsy Device Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Breast Biopsy Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Breast Biopsy Device Market, by Country

  • 16.1. United States
  • 16.2. Germany
  • 16.3. China
  • 16.4. United Kingdom
  • 16.5. India
  • 16.6. Japan
  • 16.7. Russia
  • 16.8. Brazil
  • 16.9. Canada
  • 16.10. Italy
  • 16.11. Mexico
  • 16.12. France
  • 16.13. Spain
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Advin Health Care
  • 18.2. Argon Medical Devices, Inc.
  • 18.3. Becton, Dickinson and Company
  • 18.4. Cook Group Incorporated
  • 18.5. Danaher Corporation
  • 18.6. FUJIFILM Corporation
  • 18.7. General Electric Company
  • 18.8. Halma plc
  • 18.9. Hologic, Inc
  • 18.10. INRAD Inc.
  • 18.11. Medline Industries, LP
  • 18.12. Medtronic PLC
  • 18.13. Merit Medical Systems, Inc.
  • 18.14. Ningbo Xinwell Medical Technology Co., LTD.
  • 18.15. PAJUNK GmbH
  • 18.16. Planmeca Oy
  • 18.17. Point Blank Medical
  • 18.18. Siemens AG
  • 18.19. SNVL Varay Laborix
  • 18.20. STERYLAB S.r.l.
  • 18.21. Suretech Medical Inc.
  • 18.22. Thermo Fisher Scientific Inc.
  • 18.23. Trivitron Healthcare
  • 18.24. Vector Medical, Inc.
  • 18.25. Zamar Care

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST BIOPSY DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BREAST BIOPSY DEVICE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BREAST BIOPSY DEVICE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BREAST BIOPSY DEVICE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL BREAST BIOPSY DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ASSAY KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ASSAY KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ASSAY KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY TABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY TABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY TABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GUIDANCE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GUIDANCE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GUIDANCE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LOCALIZATION WIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOCALIZATION WIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LOCALIZATION WIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORE NEEDLE BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORE NEEDLE BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORE NEEDLE BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FINE NEEDLE ASPIRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FINE NEEDLE ASPIRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FINE NEEDLE ASPIRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VACUUM ASSISTED BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VACUUM ASSISTED BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VACUUM ASSISTED BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MRI GUIDED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MRI GUIDED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MRI GUIDED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STEREOTACTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STEREOTACTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STEREOTACTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TOMOSYNTHESIS GUIDED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TOMOSYNTHESIS GUIDED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TOMOSYNTHESIS GUIDED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND GUIDED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND GUIDED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND GUIDED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MANUAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MANUAL BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MANUAL BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BENIGN LESION DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BENIGN LESION DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BENIGN LESION DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MALIGNANT LESION DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MALIGNANT LESION DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MALIGNANT LESION DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OFFLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OFFLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OFFLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 136. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 160. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. INDIA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 206. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 208. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 209. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 214. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 217. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 222. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 224. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 225. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. ITALY BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 246. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 248. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 249. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 262. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 278. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 280. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 281. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 286. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 288. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 289. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. GLOBAL BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 293. GLOBAL BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025